User:Waltpren/Books/ONCOLOGY IMMUNOLOGY G - H
Appearance
The Wikimedia Foundation's book rendering service has been withdrawn. Please upload your Wikipedia book to one of the external rendering services. |
You can still create and edit a book design using the Book Creator and upload it to an external rendering service:
|
This user book is a user-generated collection of Wikipedia articles that can be easily saved, rendered electronically, and ordered as a printed book. If you are the creator of this book and need help, see Help:Books (general tips) and WikiProject Wikipedia-Books (questions and assistance). Edit this book: Book Creator · Wikitext Order a printed copy from: PediaPress [ About ] [ Advanced ] [ FAQ ] [ Feedback ] [ Help ] [ WikiProject ] [ Recent Changes ] |
ONCOLOGY IMMUNOLOGY G - H
[edit]November 2015
[edit]- 310 helix
- 7 3 (chemotherapy)
- Abciximab
- ABO blood group system
- ABVD
- Accelerated phase chronic myelogenous leukemia
- Activin and inhibin
- Acute basophilic leukemia
- Acute biphenotypic leukaemia
- Acute eosinophilic leukemia
- Acute erythroid leukemia
- Acute lymphoblastic leukemia
- Acute megakaryoblastic leukemia
- Acute monocytic leukemia
- Acute myeloblastic leukemia
- Acute myeloblastic leukemia with maturation
- Acute myeloblastic leukemia without maturation
- Acute myeloid dendritic cell leukemia
- Acute myeloid leukemia
- Acute myelomonocytic leukemia
- Acute panmyelosis with myelofibrosis
- Acute promyelocytic leukemia
- Acylation stimulating protein
- Adaptive immune system
- ADE (chemotherapy)
- Adenomatous polyposis coli
- Adiponectin
- Adipose-derived hormones
- Adjuvant
- Adoptive cell transfer
- Adrenocorticotropic hormone
- Adult T-cell leukemia/lymphoma
- Aggressive NK-cell leukemia
- Agouti gene
- Agouti signalling peptide
- AL amyloidosis
- Aldo-keto reductase
- Alemtuzumab
- Alkylating antineoplastic agent
- Allatostatin
- Allergic response
- Allergy
- Allotransplantation
- Alpha helix
- Alpha sheet
- Alpha solenoid
- Alpha-Melanocyte-stimulating hormone
- Amgen
- Amide ring
- Amino acid
- Amylin
- Amylin family
- Amyotrophic lateral sclerosis
- Anaplasia
- Anaplastic astrocytoma
- Angiogenesis
- Angiopoietin
- Angiotensin
- Ankyrin repeat
- Antagonist
- Anti-CD22 immunotoxin
- Antibody
- Antibody-dependent cell-mediated cytotoxicity
- Antigen
- Antigen-antibody interaction
- Antigen-presenting cell
- Antigenic variation
- Apoptosis
- Astrocytoma
- Asx motif
- Asx turn
- Atrial natriuretic peptide
- Autochaperone
- Autocrine signalling
- AXIN1
- B cell
- B-box zinc finger
- B-cell chronic lymphocytic leukemia
- B-cell prolymphocytic leukemia
- B-cell receptor
- B7 (protein)
- Basic fibroblast growth factor
- Basic helix-loop-helix
- Basiliximab
- Bavituximab
- BEACOPP
- Benign tumor
- Beta barrel
- Beta bend ribbon
- Beta bulge
- Beta bulge loop
- Beta hairpin
- Beta helix
- Beta sheet
- Beta turn
- Beta-catenin
- Beta-Melanocyte-stimulating hormone
- Beta-propeller
- Beta-sandwich
- Betacellulin
- Betatrophin
- Big gastrin
- Biological life cycle
- Biphenotype acute leukemia
- Blastic phase chronic myelogenous leukemia
- Blood type
- Blood–brain barrier
- Bone growth factor
- Bone marrow
- Bone marrow suppression
- Bone morphogenetic protein
- Bone tumor
- Bovine somatotropin
- Bradykinin
- Brain ischemia
- Brain tumor
- Brain-derived neurotrophic factor
- BRCA1
- Breast cancer
- Brodalumab
- Calcitonin
- Cancer
- Cancer (disambiguation)
- Cancer immunotherapy
- Cancer signs and symptoms
- Cancer stem cell
- Carcinogen
- Carcinogenesis
- Carcinoma
- Carcinoma in situ
- Carmustine
- Catecholamine
- Catgrip
- CATH database
- CCL5
- CCN intercellular signaling protein
- CD20
- CD3 (immunology)
- CD4
- CD52
- CD8
- CD80
- CD86
- Cell (biology)
- Cell biology
- Cell culture
- Cell division
- Cell membrane
- Cell nucleus
- Cell physiology
- Cell signaling
- Cell surface receptor
- Cell-mediated immunity
- Central nervous system
- Cetuximab
- Chemotherapy
- Chimeric antigen receptor
- Chromosome
- Chronic eosinophilic leukemia
- Chronic myelogenous leukemia
- Chronic myelomonocytic leukemia
- Chronic neutrophilic leukemia
- Chronic phase chronic myelogenous leukemia
- Ciliary neurotrophic factor
- Clonal selection
- Cluster of differentiation
- Coiled coil
- Collagen helix
- Colony-stimulating factor
- Complement system
- Complementarity determining region
- Conatumumab
- Corpus callosum
- Corticotropin-releasing hormone
- Cortisol
- Craniotomy
- CRISPR
- Crosslinking of DNA
- Crustacean neurohormone family
- Cryoglobulinemia
- CTGF
- CTLA-4
- Cytokine
- Cytokine-induced killer cell
- Cytotoxic T cell
- Cytotoxicity
- Darbepoetin alfa
- Death fold
- Deauville Criteria
- Dendritic cell
- Denosumab
- Diablo homolog
- Diffuse large B-cell lymphoma
- DNA
- DNA clamp
- DNA damage (naturally occurring)
- DNA-binding protein
- DT-PACE
- Dysplasia
- EF hand
- Endocrine gland neoplasm
- Endocrine system
- Endoglin
- Endothelin
- Endothelium
- Enteric nervous system
- Enteroglucagon
- Eosinophil granulocyte
- Epidermal growth factor
- Epidermal growth factor receptor
- Epinephrine
- Epithelial–mesenchymal transition
- Epitope
- Epoetin alfa
- Epoetin beta
- Erythema multiforme
- Erythrocyte sedimentation rate
- Erythroferrone
- Erythropoietin
- Escherichia coli
- Etanercept
- Eukaryotic Linear Motif resource
- Evolocumab
- F-box protein
- FANCF
- Fc receptor
- Fellutamide
- Ferredoxin fold
- FGF15
- FGF15/19
- FGF19
- Fibrillary astrocytoma
- Fibroblast growth factor
- Fibroblast growth factor 23
- Filgrastim
- Flavodoxin fold
- FNDC5
- Folding@home
- Follicle-stimulating hormone
- Follicular B helper T cells
- Follicular lymphoma
- Fragment antigen-binding
- Fragment crystallizable region
- Frizzled
- Fusion protein
- G-CSF factor stem-loop destabilising element
- Gamma-Melanocyte-stimulating hormone
- Ganitumab
- Gastrin
- Gastroinhibitory peptide
- Gefitinib
- Gene therapy
- Genetic engineering
- Genetics
- Ghrelin
- Glia maturation factor
- Glial cell line-derived neurotrophic factor
- Glioblast
- Glioblastoma multiforme
- Glioma
- Globin fold
- Glucagon
- Glucagon-like peptide-1
- Glutamic acid
- Glutamine
- Glycophosphatidylinositol
- Glycoprotein
- Golgi apparatus
- Gonadotropin
- Gonadotropin preparations
- Gonadotropin release inhibitor
- Gonadotropin-releasing hormone
- Granin
- Granulocyte
- Granulocyte colony-stimulating factor
- Granulocyte colony-stimulating factor receptor
- Granulocyte macrophage colony-stimulating factor
- Granzyme B
- Greek key (protein structure)
- Growth differentiation factor-9
- Growth factor
- Growth factor receptor
- Growth factor receptor inhibitor
- Growth Factors (journal)
- Growth hormone
- Growth hormone–releasing hormone
- Haematopoiesis
- Heavy chain disease
- Heberprot-P
- Helix bundle
- Helix-turn-helix
- Hematinic
- Hematology
- Hematopoietic stem cell
- Hematopoietic stem cell transplantation
- Hemiparesis
- Hemopoietic growth factors
- Heparin-binding EGF-like growth factor
- Hepatocyte growth factor
- Hepcidin
- Heptad repeat
- HER2/neu
- Hes3 signaling axis
- Hodgkin's lymphoma
- Homology (biology)
- Horizontal gene transfer
- Hormone
- Human blood group systems
- Human body
- Human chorionic gonadotropin
- Human papillomavirus
- Human placental lactogen
- Humanized antibody
- Humoral immunity
- Hydrocephalus
- Hyperplasia
- Imatinib
- Immune checkpoint
- Immune network theory
- Immune receptor
- Immune system
- Immunogenicity
- Immunoglobulin A
- Immunoglobulin D
- Immunoglobulin domain
- Immunoglobulin E
- Immunoglobulin G
- Immunoglobulin heavy chain
- Immunoglobulin light chain
- Immunoglobulin M
- Immunoglobulin superfamily
- Immunology
- Immunoproliferative disorder
- Immunoproteomics
- Immunoreceptor tyrosine-based inhibitory motif
- Immunostimulant
- Incretin
- Infectious causes of cancer
- Infliximab
- Inhibitor cystine knot
- Inhibitor of apoptosis domain
- Innate immune system
- Insulin
- Insulin analog
- Insulin aspart
- Insulin degludec
- Insulin glargine
- Insulin lispro
- Insulin-like growth factor
- Insulin-like growth factor 1
- Insulin-like growth factor 2
- Interferon
- Interferon alpha 1
- Interferon gamma
- Interferon gamma receptor 1
- Interleukin
- Interleukin 1 family
- Interleukin 12
- Interleukin 2
- Interleukin 3
- Interleukin 6
- International Classification of Diseases for Oncology
- Intracellular receptor
- Intracrine
- Intron
- Ipilimumab
- Isocitrate dehydrogenase
- JAK-STAT signaling pathway
- Juvenile myelomonocytic leukemia
- Kelch motif
- Keratinocyte growth factor
- Knobs into holes packing
- Krüppel associated box
- Lenograstim
- Leptin
- Leucine zipper
- Leucine-rich repeat
- Leukapheresis
- Leukemia
- Leukocyte extravasation
- Leukotriene
- Ligand
- Ligand (biochemistry)
- Light chain deposition disease
- Limostatin
- Liraglutide
- List of IARC Group 1 carcinogens
- List of IARC Group 2A carcinogens
- Little gastrin I
- Li–Fraumeni syndrome
- Local hormone
- Low-affinity nerve growth factor receptor
- Luteinizing hormone
- Lymph node
- Lymphatic system
- Lymphoblast
- Lymphocyte
- Lymphoid leukemia
- Lymphokine
- Lymphokine-activated killer cell
- Lymphoma
- Lymphopoiesis
- Lymphoproliferative disorders
- Macrophage
- Macrophage colony-stimulating factor
- Major histocompatibility complex
- Malignancy
- Mammal
- Marc de Garidel
- Mast cell
- Mast cell leukemia
- Medulloblastoma
- Melanocortin
- Melanocyte-stimulating hormone
- Memory B cell
- Messenger RNA
- Metastasis
- Methylation
- MHC class II
- Mimesis
- Minigastrin
- Mismatch repair cancer syndrome
- Mitochondrion
- Mitogen-activated protein kinase
- Monoclonal antibody
- Monoclonal gammopathy of undetermined significance
- Monocyte
- Monokine
- Mucosal immunology
- Muller's morphs
- Multiple myeloma
- Mutagen
- Mutagenesis
- Myeloid
- Myeloid sarcoma
- Myeloma protein
- Myostatin
- N-terminal prohormone of brain natriuretic peptide
- Natural killer cell
- Natural killer T cell
- Necrosis
- Neoplasm
- Nerve growth factor
- Nest (protein structural motif)
- Neurofibromatosis
- Neurofibromin 1
- Neurogenesis
- Neuroglia
- Neuropeptide VF precursor
- Neuroplasticity
- Neurotransmitter
- Neurotrophin
- Neurotrophin-3
- Neurotrophin-4
- Neutropenia
- Neutrophil granulocyte
- Niche (protein structural motif)
- Nodular lymphocyte predominant Hodgkin's lymphoma
- Non-Hodgkin lymphoma
- Non-small-cell lung carcinoma
- Norepinephrine
- NPH insulin
- Null cell
- O-6-methylguanine-DNA methyltransferase
- O6-Benzylguanine
- Obestatin
- Omega loop
- OMPdb
- Oncogene
- Oncology
- Oncomodulin
- Orphan drug
- Osteocalcin
- Osteopromotive
- Otelixizumab
- Oxidative stress
- P53
- Palifermin
- Paracrine signalling
- Paraproteinemia
- Parathyroid hormone
- Passive immunity
- Pathogenesis
- Pathology
- Pattern recognition receptor
- PD-L1
- PDCD1LG2
- PDGFB
- Pegfilgrastim
- Pentapeptide repeat
- Peptide
- Perforin
- Performance status
- Peripheral T-cell lymphoma
- Phage display
- Phagocyte
- Phagocytosis
- Phagosome
- PHD finger
- Phosphoinositide 3-kinase
- Phosphorylation
- Pi helix
- Placental growth factor
- Plasma cell
- Plasma cell dyscrasia
- Plasma cell leukemia
- Plasmacytoma
- Platelet alpha-granule
- Platelet-derived growth factor
- Platelet-derived growth factor receptor
- Pleiotrophin
- POEMS syndrome
- Polyethylene glycol
- Polyproline helix
- Precursor B-cell lymphoblastic leukemia
- Proliferative index
- Prolymphocyte
- Protein
- Protein domain
- Protein engineering
- Protein fold class
- Protein I-sites
- Protein kinase B
- Protein kinase inhibitor
- Pt-barrel
- PubMed
- Radical (chemistry)
- Receptor (biochemistry)
- Receptor tyrosine kinase
- Recombinant DNA
- Reed–Sternberg cell
- Regulatory T cell
- Rh blood group system
- Rho(D) immune globulin
- RING finger domain
- Rituximab
- Rossmann fold
- Sarcoma
- Schellman loop
- Sequential high-dose chemotherapy
- Short linear motif
- Side-chain theory
- Signal transduction
- Simple Modular Architecture Research Tool
- Sperm
- ST motif
- ST staple
- ST turn
- Stanford V
- STAT3
- Stem cell
- Sterile alpha motif
- Structural Classification of Proteins database
- Structural motif
- Supersecondary structure
- Syngenic
- T cell
- T cell receptor
- T helper 17 cell
- T helper 3 cell
- T helper cell
- T-cell growth factor
- T-cell prolymphocytic leukemia
- T-lymphoblastic leukemia/lymphoma
- TAL effector
- Tamoxifen
- Teratology
- Thioredoxin fold
- Thomas Hodgkin
- Thrombopoietin
- Thymus
- TIM barrel
- TLR3
- TLR7
- TLR8
- TMPad
- Transcription activator-like effector nuclease
- Transcription factor
- Transfer RNA
- Transforming growth factor
- Transmembrane domain
- Trefoil knot fold
- Triple helix
- Trk receptor
- Tropomyosin receptor kinase A
- Tuberous sclerosis
- Tumefactive multiple sclerosis
- Tumor necrosis factor alpha
- Tumors of the hematopoietic and lymphoid tissues
- Turn (biochemistry)
- Tyrosine kinase
- Ubiquitin-interacting motif
- University of Texas MD Anderson Cancer Center
- Vaccine-naive
- Vascular endothelial growth factor
- Vascular tumor
- Ventricular system
- Vesicle (biology and chemistry)
- Viral envelope
- Von Hippel–Lindau disease
- Waldenström's macroglobulinemia
- Walker motifs
- White blood cell
- Wnt signaling pathway
- Zinc finger
- Zinc finger chimera
- Zinc finger inhibitor
- Zinc finger nuclease
- Zinc finger transcription factor